Zachary W. Reichenbach, Ph.D. - Publications
Affiliations: | 2015 | Physiology | Temple University, Philadelphia, PA, United States |
Area:
Neuroscience Biology, Immunology, PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2022 | Reichenbach ZW, DiMattio K, Rajakaruna S, Ambrose D, Cornwell WD, Tallarida RJ, Rogers T, Liu-Chen LY, Tuma RF, Ward SJ. Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966. Frontiers in Pharmacology. 13: 803331. PMID 35529434 DOI: 10.3389/fphar.2022.803331 | 0.54 | |||
2017 | Ward SJ, Castelli F, Reichenbach ZW, Tuma RF. Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sciences. PMID 29288767 DOI: 10.1016/J.Lfs.2017.12.030 | 0.565 | |||
2016 | Reichenbach ZW, Li H, Ward SJ, Tuma RF. The CB1 Antagonist, SR141716A, Is Protective in Permanent Photothrombotic Cerebral Ischemia. Neuroscience Letters. PMID 27453059 DOI: 10.1016/J.Neulet.2016.07.041 | 0.571 | |||
2015 | Reichenbach ZW, Li H, Gaughan JP, Elliott M, Tuma R. IV and IP administration of rhodamine in visualization of WBC-BBB interactions in cerebral vessels. Microscopy Research and Technique. PMID 26207355 DOI: 10.1002/Jemt.22552 | 0.534 | |||
2015 | Neelakantan H, Tallarida RJ, Reichenbach ZW, Tuma RF, Ward SJ, Walker EA. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behavioural Pharmacology. 26: 304-14. PMID 25485642 DOI: 10.1097/Fbp.0000000000000119 | 0.552 | |||
2012 | Wu W, Li H, Navaneetham D, Reichenbach ZW, Tuma RF, Walsh PN. The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis. Blood. 120: 671-7. PMID 22674803 DOI: 10.1182/Blood-2012-03-419523 | 0.542 | |||
Show low-probability matches. |